MétaCan
Menu
Back to cohort
Record W2940618041 · doi:10.5489/cuaj.6015

Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma

2019· article· en· W2940618041 on OpenAlexaffvenueabout
Mark Warren, Michael Kolinsky, Christina M. Canil, Piotr Czaykowski, Srikala S. Sridhar, Peter C. Black, Christopher M. Booth, Wassim Kassouf, Libni Eapen, Som D. Mukherjee, Normand Blais, Bernhard J. Eigl, Eric Winquist, Naveen S. Basappa, Scott North

Bibliographic record

VenueCanadian Urological Association Journal · 2019
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsLondon Health Sciences CentreBC Cancer AgencyCentre Hospitalier de l’Université de MontréalUniversity of OttawaMcGill University Health CentreSpinal Cord Injury BCQueen's UniversityUniversity of British ColumbiaPrincess Margaret Cancer CentreUniversity Health NetworkCancerCare ManitobaOttawa HospitalJuravinski Cancer CentreUniversity of ManitobaWestern UniversityUniversity of TorontoUniversity of Alberta
Fundersnot available
KeywordsMedicineGenitourinary systemOncologyBladder cancerDiseaseInternal medicineCancerStage (stratigraphy)Renal pelvisUreterUrology

Abstract

fetched live from OpenAlex

Warren et al Unresectable locally advanced and metastatic urothelial carcinoma advances in systemic therapy, especially due to the emergence of immunotherapy as a therapeutic option, a consensus opinion has become necessary to guide the management of unresectable locally advanced and metastatic urothelial carcinoma. MethodsA literature review was undertaken evaluating studies of unresectable locally advanced and metastatic urothelial carcinoma with a greater emphasis on prospective randomized studies.A search of Medline, Embase and Pubmed in addition to other published guidelines was used to identify relevant studies.A summary of the evidence was created with draft recommendations pertaining to various aspects of the management of advanced urothelial carcinoma.This was distributed to members of GUMOC for review and discussion through which a consensus opinion was established.The following statements focus predominantly on systemic management which falls in the realm of the Medical Oncology specialty.Additionally, the management of advanced, unresectable urothelial cancer is multidisciplinary in nature as there are times when surgery and / or radiotherapy have a role to play, particularly in patients with oligometastatic disease and those with locally advanced disease.In this consensus statement, we define locally advanced disease as cT4b and / or cN1-3.Statements pertaining to these aspects of management are intended to provide guidance for treating clinicians as to when to consider referral for multidisciplinary discussion.They are not intended to mandate a particular management plan that arises from such a forum.All recommended systemic treatment regimens are outlined in Table 1.Systemic therapy for unresectable locally advanced and metastatic urothelial carcinoma

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.025
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.667
Threshold uncertainty score0.670

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.025
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.003
Science and technology studies0.0070.003
Scholarly communication0.0030.002
Open science0.0050.002
Research integrity0.0080.009
Insufficient payload (model declined to judge)0.0080.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.010
GPT teacher head0.244
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2019
Admission routes3
Has abstractyes

Explore more

Same venueCanadian Urological Association JournalSame topicBladder and Urothelial Cancer TreatmentsFrench-language works237,207